If prescribed, medication, syringes, alcohol pads, and instructions are provided as part of the program
Tight junction restoration: BPC-157 (claudin-2, occludin), KPV (ZO-1), and Semax (claudin-2, occludin) all upregulate tight junction proteins
"Combining BPC-157 with TB-500 offers a multi-pathway template for analyzing soft tissue repair, leveraging both F-actin and angiogenic signals." Peer-reviewed literature on both components is thoroughly indexed in PubMed at the PubMed Synergetic Research Index and structural models are cataloged at PubChem Compound Databases
A generalized hierarchy for medication preferences that would apply to all overweight patients cannot currently be scientifically justified
Athletes should note that these compounds fall within categories prohibited by the World Anti-Doping Agency and are not permitted in tested competition.
Some studies document pain, swelling, redness, bruising, and itching resulting from a variety of factors: Histamine release, immune response to the peptide, needle trauma, and/or irritation from preservatives and buffers